PRNewswire Mahwah (New Jersey) [US]/ Mumbai (Maharashtra) [India], November 7: Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg, the generic version of Prolixin1 Tablets, 1 mg,…Read More
Glenmark Pharma receives ANDA approval for Fluphenazine Hydrochloride Tablets USP 1 mg 25 mg 5 mg and 10 mg
